Neurogenic orthostatic hypotension
Clinical trials for Neurogenic orthostatic hypotension explained in plain language.
Never miss a new study
Get alerted when new Neurogenic orthostatic hypotension trials appear
Sign up with your email to follow new studies for Neurogenic orthostatic hypotension, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Drug combo aims to fix standing blood pressure drop without Lying-Down spike
Disease control By invitation onlyThis study tests whether combining two drugs, droxidopa and pyridostigmine, can improve a sudden drop in blood pressure when standing up (orthostatic hypotension) without making high blood pressure worse when lying down. The trial enrolls people with neurogenic orthostatic hypote…
Matched conditions: NEUROGENIC ORTHOSTATIC HYPOTENSION
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug aims to stop the dizziness of standing up
Symptom relief OngoingThis study tests a new drug called CST-3056 in 12 adults with neurogenic orthostatic hypotension (a sharp drop in blood pressure when standing) caused by Parkinson's disease or pure autonomic failure. The goal is to see if the drug can improve blood pressure and reduce symptoms l…
Matched conditions: NEUROGENIC ORTHOSTATIC HYPOTENSION
Phase 2 • Sponsor: CuraSen Therapeutics, Inc. • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC